Mingyan Du
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
- Ocular Diseases and Behçet’s Syndrome
-
- Retinal Imaging and Analysis
Papers in
-
- Retinal Diseases and Treatments 3
- Glaucoma and retinal disorders 1
-
- Retinal Imaging and Analysis 3
- Co-authors
- Jie Li (2 shared papers)Lulin Huang (3 shared papers)Chao Qu (3 shared papers)Yanhui Deng (2 shared papers)Ling Wan (1 shared paper)Lifeng Qiao (1 shared paper)Ping Shuai (1 shared paper)Haixin Wang (1 shared paper)
- Journals
- Scientific Reports (1 paper)RSC Medicinal Chemistry (1 paper)Aging (1 paper)Genes & Diseases (1 paper)Biomedical Signal Processing and Control (1 paper)
- Partner nations
- China
In The Last Decade
Mingyan Du
5 papers receiving 271 citations
Mingyan Du's Hit Papers
Peers
Comparison fields: 5 of 73
- Ophthalmology 174
- Radiology, Nuclear Medicine and Imaging 102
- Neurology 20
- Biochemistry 10
- Clinical Biochemistry 10
Countries citing papers authored by Mingyan Du
This map shows the geographic impact of Mingyan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyan Du more than expected).
Fields of papers citing papers by Mingyan Du
This network shows the impact of papers produced by Mingyan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyan Du. The network helps show where Mingyan Du may publish in the future.
Co-authors
The 24 scholars most cited alongside Mingyan Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy Hit paper breakdown → | 2021 | 234 |
| 2 | 2021 | 26 | |
| 3 | 2023 | 7 | |
| 4 | 2024 | 6 | |
| 5 | 2022 | 4 | |
| 6 | 2024 | 0 |
About Mingyan Du
Mingyan Du is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine, Cognitive Neuroscience and Oncology, having authored 6 papers that have together received 277 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (3 papers), Retinal Imaging and Analysis (3 papers), EEG and Brain-Computer Interfaces (2 papers), ECG Monitoring and Analysis (2 papers), Peptidase Inhibition and Analysis (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Glaucoma and retinal disorders (1 paper) and Atrial Fibrillation Management and Outcomes (1 paper). The work is most often cited by research in Ophthalmology (174 citations), Radiology, Nuclear Medicine and Imaging (102 citations), Neurology (20 citations), Biochemistry (10 citations) and Clinical Biochemistry (10 citations). Mingyan Du has collaborated with scholars based in China. Frequent co-authors include Jie Li, Lulin Huang, Chao Qu, Yanhui Deng, Ling Wan, Lifeng Qiao, Ping Shuai, Haixin Wang, Peirong Huang and Shanshan Zhang. Their work appears in journals such as Scientific Reports, RSC Medicinal Chemistry, Aging, Genes & Diseases and Biomedical Signal Processing and Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.